Advertisement
Screener

AGENUS INC (AGEN) Material Contracts

AGENUS INC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-07-13: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement, dated July 13, 2026, by and between Agenus Inc. and the other parties thereto..
  • 2026-07-13: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated July 13, 2026, by and between Agenus Inc. and each purchaser thereto..
  • 2025-11-10: Form 10-Q; Exhibit 10.3; Description Form of Convertible Promissory Note by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith..
  • 2025-11-10: Form 10-Q; Exhibit 10.2; Description Convertible Promissory Note Purchase Agreement by and between MiNK Therapeutics Inc. and Agenus Inc., dated February 12, 2024. Filed herewith..
FiledFormExhibitDescription
2026-07-138-K10.2Form of Registration Rights Agreement, dated July 13, 2026, by and between Agenus Inc. and the other parties thereto.
2026-07-138-K10.1Form of Securities Purchase Agreement, dated July 13, 2026, by and between Agenus Inc. and each purchaser thereto.

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60